Workflow
Krypton system
icon
Search documents
Teradyne's UltraFLEXplus Gains Traction: A Sign for More Upside?
ZACKS· 2025-12-24 18:36
Core Insights - Teradyne (TER) is experiencing growth due to the increasing demand for its UltraFLEXplus system, which is tailored for the complex testing needs of high-performance processors and networking devices [1][11] Semiconductor Test Business - The UltraFLEXplus system has significantly contributed to the Semiconductor Test business, with revenues increasing by 7% year over year and 23% sequentially in Q3 2025, making up 78.8% of total sales for the quarter [2][11] - Teradyne launched the UltraPHY 224G instrument for the UltraFLEXplus platform in September 2025, enhancing its high-speed PHY test capabilities beyond the previous UltraPHY 112G [3] - The UltraPHY 224G includes integrated DSO, AWG, and BERT functionalities, catering to next-generation data center and silicon photonics interfaces, and allows for comprehensive testing of current and future high-speed standards [4] Market Demand and Revenue Projections - The demand for AI-driven applications, especially in data centers, is anticipated to further boost the adoption of UltraFLEXplus, contributing to top-line growth [5] - For Q4 2025, Teradyne projects revenues between $920 million and $1 billion [5] Competitive Landscape - Teradyne faces strong competition in the semiconductor test market from Advantest Corporation and Cohu [6] - Advantest has introduced the T2000 AiR2X, a next-generation air-cooled semiconductor test system that offers double the test resources of its predecessor while maintaining low power usage [7] - Cohu has expanded its portfolio with the Eclipse platform and secured new orders for its Krypton system, enhancing its position in the semiconductor test market [8] Stock Performance and Valuation - Teradyne's shares have increased by 119.6% over the past six months, outperforming the Zacks Computer & Technology sector's growth of 22.1% and the Zacks Electronics - Miscellaneous Products increase of 25.7% [9] - The stock is trading at a forward 12-month Price/Sales ratio of 8.39X, higher than the industry average of 7.05X, indicating a premium valuation [13] - The consensus estimate for fiscal 2026 earnings is $3.51 per share, reflecting a year-over-year growth of 9.01% [16]